insights_auto
Why is 0QF down 3,38%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
170,86 €
arrow_downward
-3,38%(-5,98) 1D
6 ოქტ, 17:35:50 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
183,54 €
High
188,30 €
Low
167,12 €
Mkt. cap
70,96 მლრდ.
Avg. vol.
31,26 ათ.
Volume
44,51 ათ.
52-wk high
188,30 €
52-wk low
19,37 €
No. of employees
5 ათ.
Open
183,54 €
High
188,30 €
Low
167,12 €
Mkt. cap
70,96 მლრდ.
Avg. vol.
31,26 ათ.
Volume
44,51 ათ.
52-wk high
188,30 €
52-wk low
19,37 €
No. of employees
5 ათ.
News stories
From web sources and news partners
CNBC
·
24 წუთის წინ
Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more
Investor's Business Daily
·
1 საათის წინ
Biotechs Sell Off — These Are The Biggest Losers
AD HOC NEWS
·
1 საათის წინ
Nasdaq adds Moderna to Nasdaq-100. Moderna stock gains 1.08 percent
The Crypto Basic
·
4 საათის წინ
Moderna Stock Jumps 7% Near 52-Week High Ahead of Nasdaq-100 Entry
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc